Home India Ministry of Commerce and Industry DPIIT and Roche India sign MoU to catalyze innovation and en...
Date: 2025-07-31 Category: Not Applicable State: Union Government Country: India

DPIIT and Roche India sign MoU to catalyze innovation and entrepreneurship in healthcare sector

Issued by Ministry of Commerce and Industry · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

**Summary:** The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Roche Products India Pvt. Ltd. The MoU aims to stimulate innovation and entrepreneurship within India's healthcare sector, specifically targeting DPIIT-recognized startups engaged in critical therapeutic areas, including oncology, neurology, ophthalmology, haematology, and rare diseases. Under the terms of the MoU, Roche India will provide participating startups with mentorship from global experts, support for pilot and validation studies, and access to advanced technologies, infrastructure, and international platforms to facilitate the scaling of innovative solutions. The partnership also includes guidance on regulatory pathways, intellectual property rights, global health standards, and opportunities for real-world validation. Key areas of focus will include capacity building in Health Economics and Outcomes Research (HEOR), Good Clinical Practices (GCP), and patient engagement. The MoU was formally signed by Dr. Sumeet Jarangal, Director, DPIIT, and Smt. Rajwinder Mehdwan, Managing Director, Roche Products India Pvt. Ltd. Shri Sanjiv, Joint Secretary, DPIIT, emphasized the importance of industry-startup collaboration in integrating disruptive health innovations into the market. The initiative reflects DPIIT's commitment to fostering public-private partnerships and positioning India as a global hub for health innovation, developing patient-centric solutions tailored to India's healthcare needs. Release ID: 2150787.

Key Entities Referenced

Ministry of Commerce and Industry: A ministry of the Government of India. DPIIT (Department for Promotion of Industry and Internal Trade): Department under the Ministry of Commerce and Industry. Roche India: Indian branch of the pharmaceutical company Roche. Memorandum of Understanding (MoU): An agreement between DPIIT and Roche India to catalyze innovation and entrepreneurship in healthcare. Smt. Rajwinder Mehdwan: Managing Director, Roche Products India Pvt. Ltd. Shri Sanjiv: Joint Secretary, DPIIT Dr. Sumeet Jarangal: Director, DPIIT Delhi: Location where the press release originated. The full name is Delhi, NCT, India
Official Source Record View Original Source →
See Full Document Text
Ministry of Commerce & Industry DPIIT and Roche India sign MoU to catalyze innovation and entrepreneurship in healthcare sector MoU to provide Indian startups access to global expertise, infrastructure and international platforms Posted On: 31 JUL 2025 4:49PM by PIB Delhi The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, signed a Memorandum of Understanding (MoU) with Roche Products (India) Pvt. Ltd. to bolster DPIIT- recognized startups working in critical therapeutic areas such as oncology, neurology, ophthalmology, haematology, and rare diseases. Under the MoU, Roche India will provide mentorship from global experts, support pilot and validation studies, and offer access to cutting-edge technologies, infrastructure, and international platforms to help scale promising innovations. The MoU was formally signed by Director, DPIIT, Dr. Sumeet Jarangal and Managing Director, Roche Products (India) Pvt. Ltd., Smt. Rajwinder Mehdwan, in the presence of senior officials from both organizations. Joint Secretary, DPIIT, Shri Sanjiv highlighted the importance of industry–startup collaboration in integrating disruptive health innovations into the market. He noted that the partnership would offer guidance on regulatory pathways, intellectual property, and global health standards, along with opportunities for real-world validation. Capacity-building in Health Economics and Outcomes Research (HEOR), Good Clinical Practices (GCP), and patient engagement will also be a key focus area. Managing Director, Roche Products (India) Pvt. Ltd., Smt. Rajwinder Mehdwan described the MoU as the beginning of a collaborative journey to support Indian healthtech startups in developing patient-centric solutions tailored to India’s healthcare needs. This MoU underscores DPIIT’s commitment to fostering impactful public-private partnerships that promote inclusive growth and position India as a global hub for health innovation. *** Abhishek Dayal/ Abhijith Narayanan/ Ishita Biswas (Release ID: 2150787)

Continue your research